Abiopharma

Quarter 2 / semi-annual report for 2026

Private issuance

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest of Director - Tang Ying

Urgent Deadline for Shareholders who lost money in shares of Nano-X Imaging Ltd. (NASDAQ: NNOX)

Management and officers – staffing as of 10.8.26

Events and transactions

dividend

The company’s liability position as of 30.6.26, by maturity dates

Q2/half-year report for 2026

Silicon Motion Technology Corporation Prices Upsized Offering of $1.0 Billion Convertible Senior Notes due 2031